Gynecologic malignancies occupy a critical intersection of pathology, molecular biology, and clinical oncology. Advances in genomics, biomarker discovery, and precision diagnostics have reshaped the way these cancers are classified,
interpreted, and managed, demanding a diagnostic approach that extends well beyond conventional morphology.
Molecular Pathology and Diagnostics of Gynecologic Malignancies has been developed to address this evolving landscape. The objective of this volume is to provide a structured, evidence-based synthesis of molecular mechanisms, diagnostic
methodologies, and clinically actionable insights relevant to cancers of the female reproductive tract. Emphasis is placed on translating molecular data into meaningful diagnostic and therapeutic decisions.
The chapters are organized to reflect contemporary practice, integrating histopathology with molecular profiling techniques such as next-generation sequencing, homologous recombination deficiency assessment,